Patil Rajendra D, Dwivedi Prabhaker, Sharma Anil K
Division of Pathology, Indian Veterinary Research Institute, Izatnagar 243 122, Uttar Pradesh, India.
Reprod Toxicol. 2006 Nov;22(4):679-87. doi: 10.1016/j.reprotox.2006.04.022. Epub 2006 Jun 14.
Ochratoxin A (OTA), a potent in vivo teratogen, has been tested in various laboratory animal species. Present investigation was conducted to determine critical dose and critical time for the developmental toxicity of OTA in pregnant Wistar rats after single oral dose administration. OTA at different graded dose levels (2-4 mg/kg body weight) and at different gestation days (6-15), caused variable developmental defects in developing fetuses. OTA at 2.75 mg/kg body weight, dissolved in 0.1 M sodium bicarbonate (vehicle) and administered by oral intubation as a single dose on one of the gestational days 6-15, caused significant maternal toxicity in the dams and various gross, visceral and skeletal anomalies in the fetuses. The major gross malformations were external hydrocephaly, incomplete closure of skull and omphalocele. Internal hydrocephaly, microphthalmia, enlarged renal pelvis and renal hypoplasia were the main internal soft tissue anomalies. Major skeletal defects were developmental defects in skull bones, sternebrae, vertebrae and ribs. The gestational days 6 and 7 were found to be the most critical for the induction of teratogenicity in rats. Single oral dose of 2.75 mg/kg body weight OTA was found to be the minimum effective teratogenic dose in pregnant Wistar rats.
赭曲霉毒素A(OTA)是一种强效的体内致畸剂,已在多种实验动物物种中进行了测试。本研究旨在确定单次口服给药后,OTA对怀孕Wistar大鼠发育毒性的临界剂量和临界时间。不同分级剂量水平(2-4毫克/千克体重)的OTA以及在不同妊娠天数(6-15天)给药,均导致发育中的胎儿出现不同程度的发育缺陷。将2.75毫克/千克体重的OTA溶解于0.1 M碳酸氢钠(赋形剂)中,在妊娠第6-15天中的某一天通过口服插管单次给药,导致母鼠出现明显的母体毒性,并使胎儿出现各种大体、内脏和骨骼异常。主要的大体畸形包括外部脑积水、颅骨未完全闭合和脐膨出。内部脑积水、小眼症、肾盂扩大和肾发育不全是主要的内部软组织异常。主要的骨骼缺陷是颅骨、胸骨、椎骨和肋骨的发育缺陷。发现妊娠第6天和第7天是大鼠致畸性诱导的最关键时期。单次口服2.75毫克/千克体重的OTA被发现是怀孕Wistar大鼠的最低有效致畸剂量。